14-277
Showing 1 - 25 of 8,082
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (BEA 2180 BR, Tiotropium Bromide, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- BEA 2180 BR
- +2 more
-
Jasper, Alabama
- +177 more
Jul 30, 2021
Carcinoma, Hepatocellular Trial in Worldwide (Refametinib (BAY86-9766))
Completed
- Carcinoma, Hepatocellular
- Refametinib (BAY86-9766)
-
Washington, District of Columbia
- +57 more
Apr 6, 2021
Relapsed/Refractory Small Cell Lung Cancer Trial in Worldwide (Tarlatamab)
Recruiting
- Relapsed/Refractory Small Cell Lung Cancer
-
Birmingham, Alabama
- +78 more
Jan 18, 2023
Colo-rectal Cancer Trial in Worldwide (Arfolitixorin, Leucovorin)
Active, not recruiting
- Colo-rectal Cancer
-
Gilbert, Arizona
- +93 more
Mar 29, 2022
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (NIS793, Nab-paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- NIS793
- +3 more
-
Fayetteville, Arkansas
- +122 more
Jan 27, 2023
Bone Metastasis, Cancer Pain Trial in Worldwide (Tanezumab)
Completed
- Bone Metastasis
- Cancer Pain
-
Rosario, Santa FE, Argentina
- +88 more
Dec 21, 2022
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer Trial in Worldwide (AZD9291 80
Active, not recruiting
- Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
- AZD9291 80 mg/40 mg + placebo
- +5 more
-
Anaheim, California
- +168 more
Nov 29, 2022
Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Rucaparib)
Completed
- Metastatic Castration Resistant Prostate Cancer
-
Birmingham, Alabama
- +148 more
Jun 14, 2022
Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)
Active, not recruiting
- Chronic Myelogenous Leukemia
- Nilotinib followed by treatment-free
-
Fort Myers, Florida
- +113 more
Apr 25, 2022
Liposarcoma, Dedifferentiated Trial in Worldwide (BI 907828, Doxorubicin)
Recruiting
- Liposarcoma, Dedifferentiated
- BI 907828
- Doxorubicin
-
Birmingham, Alabama
- +131 more
Feb 2, 2023
Gastric Cancer Trial in Shanghai (Oxaliplatin, Teysuno, Transarterial chemoembolization (TACE))
Not yet recruiting
- Gastric Cancer
- Oxaliplatin
- +2 more
-
Shanghai, Shanghai, ChinaZhongShan hospital FuDan university
May 25, 2022
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Worldwide (Atezolizumab, Placebo)
Active, not recruiting
- Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Atezolizumab
- Placebo
-
Duarte, California
- +134 more
Aug 18, 2022
Autism Spectrum Disorder, Anxiety Trial in Sacramento (Sertraline, CBT/BIACA, Placebo)
Active, not recruiting
- Autism Spectrum Disorder
- Anxiety
- Sertraline
- +2 more
-
Sacramento, CaliforniaUC Davis MIND Institute
Jan 5, 2023
Lung Cancer Trial in Worldwide (Nivolumab, Topotecan, Amrubicin)
Progression-free Survival Trial (Sovalteinib Solutumab Tegeo)
Not yet recruiting
- Progression-free Survival
- Sovalteinib Solutumab Tegeo
- (no location specified)
Jul 24, 2023
NSCLC Trial in Worldwide (Alectnib, Cisplatin, Vinorelbine)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Alectnib
- +5 more
-
Chicago, Illinois
- +140 more
Jan 20, 2023
Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)
Recruiting
- Medullary Thyroid Cancer
- Selpercatinib
- +2 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2023
Human Papilloma Virus, Cervical Dysplasia Trial in Washington (Educational video)
Recruiting
- Human Papilloma Virus
- Cervical Dysplasia
- Educational video
-
Washington, District of ColumbiaStephanie Wang
Feb 23, 2023
Artificial Abortion, PONV(Post Operative Nausea and Vomiting) Trial in Beijing (early vaginal administration of carboprost
Completed
- Artificial Abortion, PONV(Post Operative Nausea and Vomiting)
- early vaginal administration of carboprost methylate
- delayed vaginal administration of carboprost methylate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 26, 2023
Subclinical Depressive Symptoms Trial in Boston (Relax, Reflect, and Empower mobile application)
Not yet recruiting
- Subclinical Depressive Symptoms
- Relax, Reflect, and Empower mobile application
-
Boston, MassachusettsNortheastern University
Jun 26, 2023